10 Jun SAHPRA undergoes training to strengthen its regulatory capabilities
04 June 2025 – The South African Health Products Regulatory Authority (SAHPRA) recently visited the Egyptian Drug Authority (EDA) at their Cairo Offices for an intensive training programme to capacitate the Regulator on how to achieve recognition for the World Health Organization (WHO) Global Benchmarking Tool (GBT) Maturity Level 3 (Ml3) in medicines.
Having signed a Memorandum of Understanding with EDA in 2023, this three-day training allowed for the cross-pollination of knowledge and capacity building on the continent.
EDA’s Centre for Continuing Professional Development conducted a training programme that provided critical knowledge and shared skills required to enhance SAHPRA’s regulatory governance, transparency, and performance monitoring.
The EDA trainers were very knowledgeable, professional, and patient in delivering training that benefited SAHPRA colleagues from the various support units, namely Quality Management System, the Office of the CEO, Human Resources, Risk and Internal Audit, Communication and Public Relations, as well as Inspectorate.
It is interventions such as this one that expand SAHPRA’s horizons, allowing it to grow in stature.
